Computer-Aided Selective Optimization of Side Activities of Talinolol

ACS Medicinal Chemistry Letters
2019.0

Abstract

Selective optimization of side activities is a valuable source of novel lead structures in drug discovery. In this study, a computer-aided approach was used to deorphanize the pleiotropic cholesterol-lowering effects of the beta-blocker talinolol, which result from the inhibition of the enzyme soluble epoxide hydrolase (sEH). X-ray structure analysis of the sEH in complex with talinolol enables a straightforward optimization of inhibitory potency. The resulting lead structure exhibited <i>in vivo</i> activity in a rat model of diabetic neuropatic pain.

Knowledge Graph

Similar Paper

Computer-Aided Selective Optimization of Side Activities of Talinolol
ACS Medicinal Chemistry Letters 2019.0
Selective Optimization of Side Activities:  Another Way for Drug Discovery
Journal of Medicinal Chemistry 2004.0
Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT)
Bioorganic &amp; Medicinal Chemistry 2021.0
Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening
Bioorganic &amp; Medicinal Chemistry Letters 2012.0
Design, synthesis and biological evaluation of 4-(1-(4(sulphanilamide)phenyl)-3-(methyl)-1H-pyrazol-5-yl)dine urea and N-acyl derivatives as a soluble epoxide hydrolase inhibitors
Medicinal Chemistry Research 2014.0
Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects
European Journal of Medicinal Chemistry 2021.0
Structure−Activity Relationships of Cycloalkylamide Derivatives as Inhibitors of the Soluble Epoxide Hydrolase
Journal of Medicinal Chemistry 2011.0
Novel soluble epoxide hydrolase inhibitors with a dihydropyrimidinone scaffold: design, synthesis and biological evaluation
MedChemComm 2016.0
Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement
Journal of Medicinal Chemistry 2009.0
Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO Inhibitor
Journal of Medicinal Chemistry 2017.0